Complete Filing Data
Lantern Pharma Inc. reported Stockholders Equity of $6.53 million for FY2025.
All values from 10-K, 20-F, and 10-Q filings on SEC EDGAR, organized by financial statement. Scroll each table horizontally for the full history. Blank cells mean Lantern Pharma Inc. did not report that metric for that period in XBRL — often because accounting standards changed which tag a company files under (for example, most companies moved revenue to the ASC-606 tag in 2018), so a metric may continue in a different row. Rows marked * merge those successor tags into one continuous series, preferring the audited value from the newest-standard tag where periods overlap.
Income Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Net Income * | -$17.1M | -$20.8M | -$16.0M | -$14.3M | -$12.4M | -$5.9M | -$2.4M |
| Operating Expenses | $18.0M | $22.2M | $17.9M | $14.4M | $12.6M | $5.9M | $2.4M |
| General And Administrative Expense | $6.5M | $6.1M | $6.0M | $5.8M | $5.0M | $3.7M | $1.5M |
| Other Comprehensive Income Loss Net Of Tax | -$128.6K | $261.5K | $263.9K | -$278.7K | -$92.7K | ||
| Research And Development Expense | $11.5M | $16.1M | $11.9M | $8.6M | $7.6M | $2.2M | |
| Operating Income Loss | -$18.0M | -$22.2M | -$17.9M | -$14.4M | -$12.6M | ||
| Other Nonoperating Income Expense | $421.1K | $692.9K | $1.2M | -$31.5K | $160.6K | ||
| Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax | -$6.6K | $115.8K | $282.3K | -$296.4K | -$92.9K | ||
| Comprehensive Income Net Of Tax | -$17.2M | -$20.5M | -$15.7M | -$14.5M | -$12.5M | ||
| Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax | -$121.9K | $145.7K | -$18.3K | $17.8K | $183.00 | ||
| Net Income Loss Available To Common Stockholders Basic | -$12.4M | -$5.9M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 | Q3 2019 | Q2 2019 | Q1 2019 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income * | -$4.2M | -$4.3M | -$4.5M | -$4.5M | -$5.0M | -$5.4M | -$3.2M | -$4.7M | -$3.9M | -$2.3M | -$4.5M | -$4.1M | -$4.1M | -$2.3M | -$2.5M | -$1.7M | -$833.4K | -$477.3K | -$669.7K | -$629.4K | -$454.0K |
| Operating Expenses | $4.3M | $4.7M | $4.8M | $5.2M | $5.4M | $5.7M | $3.5M | $5.2M | $4.3M | $2.1M | $4.4M | $4.1M | $4.1M | $2.5M | $2.5M | $1.7M | $833.4K | $477.3K | $669.7K | $629.4K | |
| General And Administrative Expense | $1.9M | $1.6M | $1.5M | $1.5M | $1.5M | $1.5M | $1.3M | $1.6M | $1.7M | $1.4M | $1.4M | $1.4M | $1.2M | $1.3M | $1.2M | $1.1M | $676.4K | $340.2K | $441.3K | $268.1K | |
| Other Comprehensive Income Loss Net Of Tax | -$7.7K | -$83.7K | -$22.3K | -$18.7K | -$8.4K | $109.3K | $123.0K | $37.8K | $71.7K | -$86.6K | -$37.0K | -$218.8K | -$55.1K | -$47.6K | |||||||
| Research And Development Expense | $2.4M | $3.1M | $3.3M | $3.7M | $3.9M | $4.3M | $2.2M | $3.6M | $2.6M | $702.3K | $3.0M | $2.7M | $3.0M | $1.2M | $1.3M | $600.8K | $157.0K | $137.1K | |||
| Operating Income Loss | -$4.3M | -$4.7M | -$4.8M | -$5.2M | -$5.4M | -$5.7M | -$3.5M | -$5.2M | -$4.3M | -$2.1M | -$4.4M | -$4.1M | -$4.1M | -$2.5M | -$1.7M | -$833.4K | |||||
| Other Nonoperating Income Expense | $71.5K | $206.1K | $87.5K | $482.5K | $260.3K | $90.2K | $115.8K | $326.1K | $284.7K | -$171.6K | -$152.6K | -$77.8K | $17.7K | $114.7K | |||||||
| Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax | $918.00 | -$468.00 | -$8.2K | $38.1K | $26.5K | $43.9K | $81.0K | $33.8K | $50.8K | -$118.6K | -$63.8K | -$212.5K | -$55.1K | -$47.6K | |||||||
| Comprehensive Income Net Of Tax | -$4.2M | -$4.4M | -$4.6M | -$4.5M | -$5.0M | -$5.3M | -$3.0M | -$4.7M | -$3.8M | -$2.4M | -$4.5M | -$4.3M | -$4.1M | -$2.4M | |||||||
| Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax | -$8.6K | -$83.2K | -$14.1K | -$56.7K | -$34.9K | $65.4K | $42.0K | $4.1K | $20.9K | $32.0K | $26.8K | -$6.3K | |||||||||
| Net Income Loss Available To Common Stockholders Basic | -$4.1M | -$4.1M | -$2.5M | -$1.7M | -$833.4K |
Balance Sheet
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Stockholders Equity * | $6.5M | $21.2M | $40.9M | $56.0M | $71.6M | $19.7M | $943.3K | -$201.8K |
| Cash And Cash Equivalents At Carrying Value | $4.4M | $7.5M | $21.9M | $37.2M | $51.5M | $19.2M | $445.2K | |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | $4.4M | $7.5M | $21.9M | $37.7M | $52.5M | $19.2M | ||
| Retained Earnings Accumulated Deficit | -$93.1M | -$76.0M | -$55.2M | -$39.3M | -$25.0M | -$12.7M | -$6.8M | |
| Property Plant And Equipment Net | $31.9K | $47.4K | $52.1K | $48.0K | $30.2K | $21.5K | $8.8K | |
| Liabilities Current | $4.5M | $4.3M | $2.7M | $2.8M | $2.3M | $552.3K | $489.3K | |
| Liabilities And Stockholders Equity | $11.0M | $25.6M | $43.6M | $58.8M | $74.0M | $20.4M | $1.4M | |
| Liabilities | $4.5M | $4.4M | $2.7M | $2.8M | $2.4M | $660.8K | $489.3K | |
| Common Stock Value | $1.1K | $1.1K | $1.1K | $1.1K | $1.1K | $622.00 | $198.00 | |
| Assets Current | $10.8M | $25.2M | $43.3M | $58.7M | $72.7M | $20.2M | $1.2M | |
| Assets | $11.0M | $25.6M | $43.6M | $58.8M | $74.0M | $20.4M | $1.4M | |
| Prepaid Expense And Other Assets Current | $683.9K | $1.2M | $2.0M | $3.0M | $2.0M | $1.0M | $788.00 | |
| Operating Lease Right Of Use Asset | $75.6K | $240.0K | $228.3K | $47.7K | $185.9K | |||
| Accounts Payable And Accrued Liabilities Current | $4.4M | $4.1M | $2.5M | $2.7M | $2.2M | $552.3K | ||
| Other Assets Noncurrent | $36.7K | $36.7K | $25.9K | $17.9K | $17.9K | |||
| Operating Lease Liability Current | $78.5K | $190.8K | $173.0K | $52.9K | $152.1K | |||
| Marketable Securities Current | $5.7M | $16.5M | $19.4M | $18.0M | $19.2M | |||
| Accumulated Other Comprehensive Income Loss Net Of Tax | $25.4K | $154.0K | -$107.5K | -$371.4K | -$92.7K | |||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | -$3.1M | -$14.4M | -$15.8M | -$14.8M | $33.3M | |||
| Unrealized Gain Loss On Investments | $305.9K | $155.6K | $119.7K | -$492.5K | -$80.6K | |||
| Operating Lease Liability Noncurrent | $52.8K | $61.5K | $52.9K | |||||
| Debt Securities Available For Sale Realized Gain Loss | $22.4K | $9.1K | -$115.8K | -$128.9K | ||||
| Debt Securities Unrealized Gain Loss | -$282.3K | -$296.4K | -$92.9K | |||||
| Right Of Use Asset Obtained In Exchange For Operating Lease Liability | $78.4K | $348.6K | $142.0K | |||||
| Stock Option Down Round Feature Increase Decrease In Equity Amount | $961.5K | $1.2M | $117.8K | |||||
| Restricted Cash | $541.2K | $1.0M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 | Q4 2019 | Q3 2019 | Q2 2019 | Q1 2019 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stockholders Equity * | $9.6M | $12.5M | $16.8M | $26.6M | $30.9M | $35.8M | $45.4M | $48.3M | $52.6M | $59.0M | $61.1M | $65.3M | $75.7M | $79.6M | $81.7M | $21.6M | $23.2M | $536.5K | $943.3K | $1.6M | $1.1M | $1.7M |
| Cash And Cash Equivalents At Carrying Value | $8.4M | $6.1M | $6.4M | $8.1M | $13.0M | $18.4M | $25.6M | $28.4M | $32.5M | $39.3M | $43.4M | $46.7M | $54.7M | $61.4M | $81.4M | $20.8M | $23.8M | $634.2K | $1.2M | $1.9M | $1.4M | |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | $8.4M | $6.1M | $6.4M | $8.1M | $13.0M | $18.4M | $25.6M | $29.0M | $33.0M | $39.8M | $43.9M | $47.2M | $55.7M | $61.4M | ||||||||
| Retained Earnings Accumulated Deficit | -$89.1M | -$84.9M | -$80.6M | -$70.2M | -$65.6M | -$60.7M | -$51.1M | -$47.9M | -$43.2M | -$35.9M | -$33.6M | -$29.1M | -$21.5M | -$17.4M | -$15.1M | -$9.8M | -$8.1M | |||||
| Property Plant And Equipment Net | $36.0K | $39.5K | $44.0K | $48.9K | $50.3K | $50.3K | $51.0K | $50.0K | $53.5K | $43.8K | $40.1K | $28.3K | $32.2K | $30.6K | $20.2K | $17.6K | $15.4K | |||||
| Liabilities Current | $4.0M | $4.9M | $4.3M | $3.6M | $4.6M | $4.0M | $2.3M | $3.0M | $2.8M | $3.1M | $5.3M | $3.1M | $1.8M | $2.7M | $664.5K | $814.6K | $2.3M | |||||
| Liabilities And Stockholders Equity | $13.6M | $17.4M | $21.1M | $30.3M | $35.6M | $39.7M | $47.8M | $51.4M | $55.5M | $62.2M | $66.4M | $68.4M | $77.6M | $82.4M | $82.5M | $22.5M | $25.6M | |||||
| Liabilities | $4.0M | $4.9M | $4.3M | $3.7M | $4.7M | $4.0M | $2.4M | $3.2M | $2.9M | $3.1M | $5.3M | $3.1M | $1.9M | $2.8M | $773.0K | $923.1K | $2.4M | |||||
| Common Stock Value | $1.1K | $1.1K | $1.1K | $1.1K | $1.1K | $1.1K | $1.1K | $1.1K | $1.1K | $1.1K | $1.1K | $1.1K | $1.1K | $1.1K | $1.1K | $622.00 | $622.00 | |||||
| Assets Current | $13.5M | $17.2M | $20.8M | $29.9M | $35.3M | $39.5M | $47.4M | $51.0M | $55.2M | $62.0M | $65.7M | $67.7M | $76.3M | $82.1M | $82.5M | $22.5M | $25.6M | |||||
| Assets | $13.6M | $17.4M | $21.1M | $30.3M | $35.6M | $39.7M | $47.8M | $51.4M | $55.5M | $62.2M | $66.4M | $68.4M | $77.6M | $82.4M | $82.5M | $22.5M | $25.6M | |||||
| Prepaid Expense And Other Assets Current | $1.1M | $1.3M | $1.1M | $1.9M | $2.0M | $1.1M | $2.5M | $2.6M | $3.1M | $3.7M | $3.5M | $2.4M | $2.5M | $2.5M | $1.1M | $1.7M | ||||||
| Operating Lease Right Of Use Asset | $93.1K | $143.2K | $192.2K | $286.6K | $213.0K | $187.2K | $268.6K | $308.3K | $255.3K | $82.9K | $117.7K | $152.0K | $219.4K | $252.5K | ||||||||
| Accounts Payable And Accrued Liabilities Current | $3.9M | $4.8M | $4.1M | $3.4M | $4.4M | $3.8M | $2.1M | $2.9M | $2.7M | $3.0M | $5.2M | $2.9M | $1.6M | $1.1M | ||||||||
| Other Assets Noncurrent | $36.7K | $36.7K | $36.7K | $36.7K | $32.0K | $25.9K | $25.9K | $25.9K | $33.0K | $17.9K | $17.9K | $17.9K | $17.9K | $17.9K | ||||||||
| Operating Lease Liability Current | $94.0K | $131.5K | $161.5K | $197.3K | $164.0K | $178.0K | $168.0K | $163.1K | $119.6K | $92.0K | $130.7K | $155.2K | $149.0K | $145.9K | ||||||||
| Marketable Securities Current | $4.0M | $9.8M | $13.3M | $20.0M | $20.3M | $20.0M | $19.4M | $19.5M | $19.1M | $18.6M | $18.8M | $18.6M | $19.2M | $18.2M | ||||||||
| Accumulated Other Comprehensive Income Loss Net Of Tax | $40.3K | $48.0K | $131.7K | -$25.3K | -$6.6K | $1.9K | -$138.8K | -$261.8K | -$299.7K | -$435.0K | -$348.5K | -$311.5K | -$102.7K | -$47.6K | ||||||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | -$1.1M | -$3.6M | -$4.7M | -$5.3M | $62.1M | -$597.8K | ||||||||||||||||
| Unrealized Gain Loss On Investments | $151.3K | $4.0K | $42.2K | -$196.0K | ||||||||||||||||||
| Operating Lease Liability Noncurrent | $13.5K | $33.4K | $94.0K | $54.7K | $15.6K | $106.5K | $150.7K | $140.6K | $13.3K | $92.0K | $130.7K | |||||||||||
| Debt Securities Available For Sale Realized Gain Loss | $10.4K | -$929.00 | -$38.0K | |||||||||||||||||||
| Debt Securities Unrealized Gain Loss | $43.9K | $50.8K | -$212.5K | |||||||||||||||||||
| Right Of Use Asset Obtained In Exchange For Operating Lease Liability | $48.8K | |||||||||||||||||||||
| Stock Option Down Round Feature Increase Decrease In Equity Amount | $245.5K | $18.5K | ||||||||||||||||||||
| Restricted Cash | $541.2K | $541.2K | $541.2K | $541.2K | $541.2K | $1.0M |
Cash Flow Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition | $650.9K | $652.1K | $1.0M | $1.2M | $961.5K | ||
| Net Cash Provided By Used In Operating Activities | -$15.7M | -$17.8M | -$14.3M | -$12.8M | -$10.6M | -$5.7M | -$2.1M |
| Increase Decrease In Accounts Payable And Accrued Liabilities | $271.8K | $1.6M | -$236.2K | $580.4K | $1.6M | $117.2K | $372.7K |
| Net Cash Provided By Used In Investing Activities | $11.1M | $3.4M | -$930.2K | $179.3K | -$19.5M | -$16.1K | -$5.7K |
| Net Cash Provided By Used In Financing Activities | $1.5M | $66.7K | -$500.0K | -$2.2M | $63.4M | $23.7M | $2.9M |
| Depreciation Depletion And Amortization | $14.6K | $10.1K | $6.8K | $3.4K | $1.6K | ||
| Payments To Acquire Marketable Securities | $14.7M | $17.3M | $8.2M | $3.9M | $19.6M | ||
| Proceeds From Sale And Maturity Of Marketable Securities | $25.8M | $20.7M | $7.3M | $4.1M | $64.1K | ||
| Increase Decrease In Operating Lease Liability | -$190.6K | -$175.7K | -$159.3K | -$158.4K | -$71.7K | ||
| Payments To Acquire Property Plant And Equipment | $1.7K | $12.6K | $18.7K | $27.8K | $15.5K | ||
| Stock Issued During Period Value Share Based Compensation Gross | $961.5K | $1.2M | $117.8K | ||||
| Share Based Compensation | $1.1M | $1.2M | $961.5K | ||||
| Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | $33.4K | -$49.5K | -$28.5K | -$10.6K | $1.1K | ||
| Increase Decrease In Prepaid Deferred Expense And Other Assets | -$554.1K | -$778.3K | -$941.4K | $1.0M | |||
| Increase Decrease In Other Operating Assets | $10.9K | $8.0K | -$34.0K | ||||
| Increase Decrease In Prepaid Expense | $984.5K | $1.0M | $788.00 | ||||
| Proceeds From Issuance Of Preferred Stock And Preference Stock | $69.0M | $26.3M | $2.9M | ||||
| Proceeds From Stock Plans | $139.6K | $52.0K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 | Q3 2019 | Q2 2019 | Q1 2019 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition | $143.7K | $160.6K | $147.8K | $179.2K | $134.2K | $134.1K | $190.8K | $392.4K | $333.5K | $301.1K | $289.5K | $267.0K | $224.4K | $245.7K | $245.5K | ||||||
| Net Cash Provided By Used In Operating Activities | -$4.4M | -$3.1M | -$3.8M | -$3.3M | -$2.1M | -$703.0K | |||||||||||||||
| Increase Decrease In Accounts Payable And Accrued Liabilities | -$15.6K | $1.3M | -$67.3K | $742.5K | $164.1K | -$41.0K | |||||||||||||||
| Net Cash Provided By Used In Investing Activities | $3.2M | -$556.2K | -$960.9K | $176.5K | |||||||||||||||||
| Net Cash Provided By Used In Financing Activities | $54.7K | -$2.2M | $64.3M | $105.3K | |||||||||||||||||
| Depreciation Depletion And Amortization | $4.1K | $3.4K | $2.0K | $1.3K | $536.00 | ||||||||||||||||
| Payments To Acquire Marketable Securities | $5.0M | $6.0M | $3.1M | ||||||||||||||||||
| Proceeds From Sale And Maturity Of Marketable Securities | $8.2M | $5.5M | $2.2M | $176.5K | |||||||||||||||||
| Increase Decrease In Operating Lease Liability | -$48.7K | -$40.9K | -$40.3K | -$38.7K | |||||||||||||||||
| Payments To Acquire Property Plant And Equipment | $1.2K | $2.2K | $8.9K | ||||||||||||||||||
| Stock Issued During Period Value Share Based Compensation Gross | $267.0K | $224.4K | $245.7K | $245.5K | $43.5K | $105.4K | $18.5K | $32.8K | $6.0K | $15.5K | |||||||||||
| Share Based Compensation | $179.2K | $134.2K | $134.1K | $190.8K | $392.4K | $333.5K | $301.1K | $267.0K | $245.5K | ||||||||||||
| Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | $2.8K | -$9.8K | -$5.0K | $2.3K | |||||||||||||||||
| Increase Decrease In Prepaid Deferred Expense And Other Assets | -$133.4K | -$901.0K | $117.6K | $440.2K | |||||||||||||||||
| Increase Decrease In Other Operating Assets | $15.1K | ||||||||||||||||||||
| Increase Decrease In Prepaid Expense | $103.1K | $131.4K | |||||||||||||||||||
| Proceeds From Issuance Of Preferred Stock And Preference Stock | |||||||||||||||||||||
| Proceeds From Stock Plans | $299.8K | $72.8K |
Per-Share & Share Counts
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Diluted EPS * | -$1.57 | -$1.93 | -$1.47 | -$1.31 | -$1.13 | -$1.37 | -$1.23 |
| Weighted Average Number Of Shares Outstanding Basic | 10.9M | 10.8M | 10.8M | 10.9M | 10.9M | ||
| Earnings Per Share Basic | $-1.57 | $-1.93 | $-1.47 | $-1.31 | $-1.13 | ||
| Common Stock Shares Outstanding | 11.3M | 10.8M | 10.7M | 10.9M | 11.1M | 6.2M | 2.0M |
| Common Stock Shares Issued | 11.3M | 10.8M | 10.7M | 10.9M | 11.1M | 6.2M | 2.0M |
| Common Stock Shares Authorized | 25.0M | 25.0M | 25.0M | 25.0M | 25.0M | 25.0M | 12.2M |
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Preferred Stock Shares Authorized | 1.0M | 1.0M | 1.0M | 1.0M | 1.0M | 1.0M | |
| Preferred Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |
| Preferred Stock Shares Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Preferred Stock Shares Issued | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Weighted Average Number Of Diluted Shares Outstanding | 10.9M | 10.8M | 10.8M | 10.9M | |||
| Weighted Average Number Of Share Outstanding Basic And Diluted | 10.9M | 4.3M | 2.0M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 | Q4 2019 | Q3 2019 | Q2 2019 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Diluted EPS * | -$0.39 | -$0.40 | -$0.42 | -$0.42 | -$0.46 | -$0.51 | -$0.29 | -$0.44 | -$0.36 | -$0.21 | -$0.41 | -$0.36 | -$0.21 | -$0.24 | -$0.27 | -$0.31 | -$0.24 | -$0.34 | -$0.32 | ||
| Weighted Average Number Of Shares Outstanding Basic | 10.8M | 10.8M | 10.8M | 10.8M | 10.8M | 10.7M | 10.9M | 10.9M | 10.9M | 10.8M | 10.8M | 10.9M | 11.2M | 11.2M | 10.1M | ||||||
| Earnings Per Share Basic | $-0.39 | $-0.40 | $-0.42 | $-0.42 | $-0.46 | $-0.51 | $-0.29 | $-0.44 | $-0.36 | $-0.21 | $-0.41 | $-0.38 | $-0.36 | $-0.21 | $-0.24 | ||||||
| Common Stock Shares Outstanding | 11.0M | 10.8M | 10.8M | 10.8M | 10.8M | 10.8M | 10.9M | 10.9M | 10.9M | 10.9M | 10.8M | 10.8M | 11.2M | 11.2M | 11.2M | 6.2M | 6.2M | ||||
| Common Stock Shares Issued | 11.0M | 10.8M | 10.8M | 10.8M | 10.8M | 10.8M | 10.9M | 10.9M | 10.9M | 10.9M | 10.8M | 10.8M | 11.2M | 11.2M | 11.2M | 6.2M | 6.2M | ||||
| Common Stock Shares Authorized | 25.0M | 25.0M | 25.0M | 25.0M | 25.0M | 25.0M | 25.0M | 25.0M | 25.0M | 25.0M | 25.0M | 25.0M | 25.0M | 25.0M | 25.0M | 25.0M | 25.0M | ||||
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | ||||
| Preferred Stock Shares Authorized | 1.0M | 1.0M | 1.0M | 1.0M | 1.0M | 1.0M | 1.0M | 1.0M | 1.0M | 1.0M | 1.0M | 1.0M | 1.0M | 1.0M | 1.0M | 1.0M | 1.0M | 3.5M | |||
| Preferred Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |||
| Preferred Stock Shares Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 2.4M | |||||
| Preferred Stock Shares Issued | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 2.4M | |||||
| Weighted Average Number Of Diluted Shares Outstanding | 10.8M | 10.8M | 10.8M | 10.8M | 10.8M | 10.7M | 10.9M | 10.9M | 10.9M | 10.8M | 10.8M | ||||||||||
| Weighted Average Number Of Share Outstanding Basic And Diluted | 11.2M | 11.2M | 10.1M | 6.2M | 2.7M | 2.0M | 2.0M | 2.0M |
Other Metrics
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Interest Income Other | $437.9K | $742.4K | $765.4K | $204.4K | $67.9K | ||
| Additional Paid In Capital | $99.7M | $97.1M | $96.3M | $95.7M | $96.7M | $32.4M | $7.7M |
| Foreign Currency Transaction Gain Loss Before Tax | $158.0K | -$219.7K | -$11.5K | -$58.6K | |||
| Investment Income Net Amortization Of Discount And Premium | $196.4K | $238.6K | $173.1K | -$81.9K | |||
| Other Noncash Expense | $189.9K | $173.2K | $160.2K | $144.6K | |||
| Stock Issued During Period Value New Issues | $66.7K | $299.8K | $64.2M | $23.4M | |||
| Stock Repurchased During Period Value | $500.0K | $2.5M | $939.7K | ||||
| Depreciation And Amortization | $17.3K | $17.3K | $14.6K | ||||
| Comprehensive Loss | -$12.5M | -$5.9M | |||||
| Increase Decrease Purchase Of Property And Equipment | $15.5K | $16.1K | $5.7K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Interest Income Other | $100.9K | $114.7K | $149.8K | $191.4K | $188.7K | $201.0K | $246.4K | $117.8K | $133.8K | $52.2K | $55.0K | $22.4K | $77.2K | $47.9K | ||||
| Additional Paid In Capital | $98.6M | $97.4M | $97.2M | $96.8M | $96.6M | $96.4M | $96.6M | $96.4M | $96.0M | $95.4M | $95.1M | $94.8M | $97.3M | $97.1M | $96.8M | $31.3M | $31.3M | |
| Foreign Currency Transaction Gain Loss Before Tax | $17.3K | -$99.3K | -$38.2K | $22.1K | ||||||||||||||
| Investment Income Net Amortization Of Discount And Premium | $71.4K | $34.1K | $60.0K | -$51.4K | ||||||||||||||
| Other Noncash Expense | $47.8K | $41.1K | $40.0K | $36.2K | ||||||||||||||
| Stock Issued During Period Value New Issues | $12.0K | $54.7K | $64.2M | $52.0K | ||||||||||||||
| Stock Repurchased During Period Value | $2.5M | |||||||||||||||||
| Depreciation And Amortization | $4.6K | $4.1K | ||||||||||||||||
| Comprehensive Loss | -$4.3M | -$4.1M | -$2.5M | -$1.7M | -$833.4K | |||||||||||||
| Increase Decrease Purchase Of Property And Equipment |
Most recent annual filing with the SEC: March 30, 2026
Data sourced from SEC EDGAR public filings as of August 6, 2026.